ACLX

Arcellx (ACLX)

Arcellx Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ACLX

1 2 3 4 5 6 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/10	05 : 17	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ACLX	Arcellx Inc
2024/05/10	05 : 05	Business Wire	Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program	NASDAQ:ACLX	Arcellx Inc
2024/05/10	05 : 05	Business Wire	Arcellx and Kite Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program	NASDAQ:ACLX	Arcellx Inc
2024/05/10	05 : 00	Business Wire	Arcellx Provides First Quarter 2024 Financial Results	NASDAQ:ACLX	Arcellx Inc
2024/05/08	05 : 00	Business Wire	Arcellx to Participate in Two Upcoming Investor Conferences	NASDAQ:ACLX	Arcellx Inc
2024/04/05	05 : 00	Business Wire	Arcellx to Participate in the 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:ACLX	Arcellx Inc
2024/03/21	05 : 00	Business Wire	Arcellx to Participate at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference	NASDAQ:ACLX	Arcellx Inc
2024/03/08	08 : 23	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ACLX	Arcellx Inc
2024/03/01	06 : 00	PR Newswire (US)	Arcellx to Participate at the TD Cowen 44th Annual Health Care Conference	NASDAQ:ACLX	Arcellx Inc
2024/02/29	06 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACLX	Arcellx Inc
2024/02/29	06 : 00	PR Newswire (US)	Arcellx Provides Fourth Quarter and Year-End 2023 Financial Results and Business Highlights	NASDAQ:ACLX	Arcellx Inc
2024/02/15	07 : 57	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ACLX	Arcellx Inc
2024/02/13	09 : 46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACLX	Arcellx Inc
2024/02/10	06 : 08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACLX	Arcellx Inc
2024/02/09	11 : 41	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ACLX	Arcellx Inc
2024/02/01	06 : 19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACLX	Arcellx Inc
2024/01/09	06 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACLX	Arcellx Inc
2024/01/09	06 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACLX	Arcellx Inc
2024/01/05	10 : 24	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ACLX	Arcellx Inc
2024/01/05	10 : 23	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ACLX	Arcellx Inc
2024/01/05	09 : 32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACLX	Arcellx Inc
2024/01/05	09 : 31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACLX	Arcellx Inc
2024/01/03	06 : 22	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:ACLX	Arcellx Inc
2023/12/29	08 : 06	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ACLX	Arcellx Inc
2023/12/29	06 : 47	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACLX	Arcellx Inc
2023/12/20	06 : 43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACLX	Arcellx Inc
2023/12/19	06 : 33	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ACLX	Arcellx Inc
2023/12/19	06 : 16	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:ACLX	Arcellx Inc
2023/12/15	07 : 52	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ACLX	Arcellx Inc
2023/12/15	07 : 50	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ACLX	Arcellx Inc